Recombinant human thyrotropin worsens renal cortical perfusion and renal function in patients after total thyroidectomy due to differentiated thyroid cancer<:/ovid:b>: .

MedStar author(s):
Citation: Thyroid. 30(5):653-660, 2020 05.PMID: 31964314Institution: MedStar Washington Hospital CenterDepartment: Medicine/EndocrinologyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Kidney/de [Drug Effects] | *Thyroid Neoplasms/su [Surgery] | *Thyroidectomy | *Thyrotropin/pd [Pharmacology] | *Thyroxine/pd [Pharmacology] | Adult | Female | Humans | Iodine Radioisotopes/tu [Therapeutic Use] | Kidney/pp [Physiopathology] | Male | Middle Aged | Thyroid Neoplasms/pp [Physiopathology] | Thyroid Neoplasms/rt [Radiotherapy] | Thyrotropin/tu [Therapeutic Use] | Thyroxine/tu [Therapeutic Use]Year: 2020Local holdings: Available online from MWHC library: August 2000 - present, Available in print through MWHC library: 1999 - 2006ISSN:
  • 1050-7256
Name of journal: Thyroid : official journal of the American Thyroid AssociationAbstract: Background Although thyrotropin (TSH) receptors (TSH-Rs) are found in many non-thyroid tissues, we know little about the direct action of TSH on these receptors. Patients after total thyroidectomy for differentiated thyroid cancer (DTC) provide an interesting model for studying this issue. The administration of exogenous TSH in patients with an established thyroid state on L-thyroxine (LT4) treatment allows us to study the effect of elevated TSH concentrations independent of thyroid status on the function of various organs, including the kidneys. The aim of this study was to assess the effects of the administration of recombinant human TSH (rhTSH) on renal perfusion and glomerular filtration in this group of patients. Methods The study included 24 patients after total thyroidectomy due to DTC, without concomitant diseases, receiving only LT4 who qualified for radioiodine treatment (RIT). For two consecutive days, the patients received rhTSH, and subsequently the RIT. Clinical and biochemical evaluation of thyroid and renal function was carried out before and 24 hours after the second dose of rhTSH, and before the RIT. On the sixth day of hospitalization, the patients' glomerular filtration rate (GFR) was re-evaluated. Kidney perfusion was assessed using Color Doppler ultrasound imaging, before and 24 hours after the second dose of rhTSH, and before the RIT. Results The administration of rhTSH to patients after total thyroidectomy due to DTC caused significant deterioration of renal perfusion after the second dose of rhTSH before the RIT, which was followed by a significant reduction in glomerular filtration. Furthermore, rhTSH did not significantly affect the hemodynamic parameters that could worsen renal function. Conclusions This study indicates that TSH alone, independent of thyroid hormone concentrations, can influence renal perfusion and renal function.All authors: Bober B, Kaminski G, Kapusta W, Kowalski L, Lubas A, Niemczyk S, Saracyn M, Wartofsky LOriginally published: Thyroid. 2020 Jan 22Fiscal year: FY2020Digital Object Identifier: Date added to catalog: 2020-02-10
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 31964314 Available 31964314

Available online from MWHC library: August 2000 - present, Available in print through MWHC library: 1999 - 2006

Background Although thyrotropin (TSH) receptors (TSH-Rs) are found in many non-thyroid tissues, we know little about the direct action of TSH on these receptors. Patients after total thyroidectomy for differentiated thyroid cancer (DTC) provide an interesting model for studying this issue. The administration of exogenous TSH in patients with an established thyroid state on L-thyroxine (LT4) treatment allows us to study the effect of elevated TSH concentrations independent of thyroid status on the function of various organs, including the kidneys. The aim of this study was to assess the effects of the administration of recombinant human TSH (rhTSH) on renal perfusion and glomerular filtration in this group of patients. Methods The study included 24 patients after total thyroidectomy due to DTC, without concomitant diseases, receiving only LT4 who qualified for radioiodine treatment (RIT). For two consecutive days, the patients received rhTSH, and subsequently the RIT. Clinical and biochemical evaluation of thyroid and renal function was carried out before and 24 hours after the second dose of rhTSH, and before the RIT. On the sixth day of hospitalization, the patients' glomerular filtration rate (GFR) was re-evaluated. Kidney perfusion was assessed using Color Doppler ultrasound imaging, before and 24 hours after the second dose of rhTSH, and before the RIT. Results The administration of rhTSH to patients after total thyroidectomy due to DTC caused significant deterioration of renal perfusion after the second dose of rhTSH before the RIT, which was followed by a significant reduction in glomerular filtration. Furthermore, rhTSH did not significantly affect the hemodynamic parameters that could worsen renal function. Conclusions This study indicates that TSH alone, independent of thyroid hormone concentrations, can influence renal perfusion and renal function.

English

Powered by Koha